Ziftomenib in Combination with Chemotherapy for Children with Relapsed/Refractory Acute Leukemia
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- LLS PedAL Initiative, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT06376162
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- LLS PedAL Initiative, LLC
- Target Recruit Count
- 98
- Registration Number
- NCT05183035
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Alliance for Childhood Diseases dba Cure 4 The Kids Foundation, Las Vegas, Nevada, United States
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- LLS PedAL Initiative, LLC
- Target Recruit Count
- 960
- Registration Number
- NCT04726241
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Nationwide Children's Hospital, Columbus, Ohio, United States
🇵🇷HIMA San Pablo Oncologic Hospital, Caguas, Puerto Rico
© Copyright 2024. All Rights Reserved by MedPath